リブラメディシーナ List of News Articles

We will be exhibiting at BioJapan 2026 On the day of the event, we will be working alongside our partner companies to address your needs. We sincerely look forward to seeing you there. [Booth No. C-66] 　　・LibraMedicina 　　・Synmax Biochemical (Intermediate manufacturing, fermentation technology, biotransformation) [Booth No. C-71 (adjacent)] ・Mycenax Biotech (CDMO, our business partner) Translated with DeepL.com (free version)

[Notice of Appointment of Director] We are pleased to announce that Makoto Kawaguchi has been appointed as a director of our company, effective April 1, 2026 (Reiwa 8), in order to strengthen our management structure. We will continue to make every effort for the development of the pharmaceutical and medical fields, and we appreciate your continued support and kindness. Thank you very much.